HanAll BioPharma Returns to Profitability with 12% Growth
HanAll BioPharma Returns to Profitability with 12% Growth
OLED Panels to Surpass 50% Market Share by 2029
https://www.partnerkim.com/wp-admin/post-new.php?post_type=post
Curocell’s Rimcato Approved as South Korea’s First Domestic CAR-T Treatment
https://www.chosun.com/english/industry-en/2026/04/29/VDGFRCSXQJHRHNW26ORQNZS52U
Chung Eui-sun Visits Beijing Motor Show to Boost Hyundai’s Chinese Market Push
https://www.partnerkim.com/wp-admin/post-new.php?post_type=post
NVIDIA’s Madison Huang Collaborates with Korean Firms on Physical AI
https://www.partnerkim.com/wp-admin/post-new.php?post_type=post https://www.partnerkim.com/wp-admin/post-new.php?post_type=post
Shinsegae Group Restructures Management Strategy Office Under Chairman Chung Yong-jin
https://www.partnerkim.com/wp-admin/post-new.php?post_type=post
Defense Acquisition Program Administration Begins Construction of Second Military Logistics Support Ship
https://www.partnerkim.com/wp-admin/post-new.php?post_type=post
Samyang Vice Chair Resigns to Focus on Buldak Core Business
https://www.partnerkim.com/wp-admin/post-new.php?post_type=post
Nexen Tire Posts 33% Profit Surge in Q1
https://www.chosun.com/english/industry-en/2026/04/29/3O2FTG77LZGCRKC7HQOWTFFPW4